AOD-9604 reconstitution calculator
- Concentration
- 2.5 mg/mL
- Doses per vial
- 16
- Weeks (1 dose/wk)
- 16
12 units (0.12 mL) on a 1 mL U-100 syringe: 300 mcg from a 5 mg vial + 2 mL water (AOD-9604).
Dosing table for a 5 mg vial
Syringe units (U-100) for each dose, by how much bacteriostatic water you add.
| Dose | 1 mL water | 2 mL water | 2.5 mL water | 3 mL water |
|---|---|---|---|---|
| 100 mcg | 2 | 4 | 5 | 6 |
| 250 mcg | 5 | 10 | 12.5 | 15 |
| 300 mcg | 6 | 12 | 15 | 18 |
| 500 mcg | 10 | 20 | 25 | 30 |
| 750 mcg | 15 | 30 | 37.5 | 45 |
| 1000 mcg | 20 | 40 | 50 | 60 |
How the math works
Concentration is the vial's milligrams divided by the water you add. Volume to draw is your dose divided by that concentration. On a U-100 syringe, 1 mL is 100 units, so units = mL × 100.
300 mcg = 0.3 mg; 0.3 mg ÷ 2.5 mg/mL = 0.12 mL
0.12 mL × 100 = 12 units
How many units is 300 mcg of AOD-9604?
With a 5 mg vial and 2 mL of bacteriostatic water, 300 mcg is 12 units (0.12 mL) on a U-100 syringe. With 1 mL of water it is 6 units. The answer always depends on how much water was added.
How much bacteriostatic water for a 5 mg AOD-9604 vial?
The water only sets the concentration; the amount of AOD-9604 in the vial stays the same. 2 mL makes 2.5 mg/mL, so 300 mcg is 12 units. 2.5 mL makes 2 mg/mL, so the same 300 mcg is 15 units. More water makes small doses easier to measure but needs more volume per injection.
How many 300 mcg doses are in a 5 mg vial?
5 mg is 5,000 mcg; 5,000 ÷ 300 = 16.67, so 16 full doses of 300 mcg. Any liquid lost in the needle and vial is not counted.
What does an AOD-9604 5mg vial give per unit?
Mixed with 2 mL, a 5 mg vial is 2.5 mg/mL and each unit is 0.025 mg, or 25 mcg; mixed with 1 mL each unit is 50 mcg.
Calculated from vial mg 5; water m L 1, 2. Formula: 5/2 = 2.5 mg/mL x 0.01 = 0.025 mg; 5/1 = 5 mg/mL x 0.01 = 0.05 mg
How to reconstitute AOD-9604?
There is no label for it. The tool follows the generic rule that strength is vial mg divided by water mL, so a 10 mg vial in 2 mL is 5 mg/mL.
Calculated from vial mg 10; water m L 2. Formula: 10/2 = 5 mg/mL
Is there a human AOD-9604 dose in the studies?
Not in the evidence file: the dose-bearing studies are in rats, mice and rabbits, and the oral rat dose was weight-based.[3]
Preset doses are round numbers for the arithmetic, not dosing guidance. Vial sizes are the ones most often mentioned for AOD-9604 in community discussions.
Every AOD-9604 dose on record is an animal dose, and none is a syringe dose
The rat study that gave a dose per kilogram used the oral route: 500 microg/kg by mouth daily for 19 days in obese Zucker rats.[3]
The mouse experiments delivered the peptide by mini-osmotic pump for 14 days, so no per-injection amount exists to convert.[4]
A separate mouse study gave AOD9604 by intraperitoneal injection for 14 days, again without a stated mass in the abstract.[5]
The rabbit osteoarthritis study is the closest to a measurable injection: 0.25 mg of AOD9604 injected into the knee joint weekly, with or without 6 mg of hyaluronic acid.[6]
Sources
- 1Metric (SI) Prefixes (NIST Reference on Constants, Units, and Uncertainty)National Institute of Standards and Technology (NIST) · 2025physics.nist.govAccessed 2 Oct 2026
- 2BASAGLAR (insulin glargine) injection, prescribing information (DailyMed)U.S. Food and Drug Administration / DailyMed (Eli Lilly and Company label) · 2026dailymed.nlm.nih.govAccessed 2 Oct 2026
- 3Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone.Hormone research · 2000PMID 11146367Accessed 2 Oct 2026
- 4Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity · 2001PMID 11673763Accessed 2 Oct 2026
- 5The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.Endocrinology · 2001PMID 11713213Accessed 2 Oct 2026
- 6Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.Annals of clinical and laboratory science · 2015PMID 26275694Accessed 2 Oct 2026
Found an error? Report a correction.